03 Oct

Interim Dividend (with Dividend Re-Investment Plan) - DUOPHARMA BIOTECH BERHAD

Interim Dividend (with Dividend Re-Investment Plan) - DUOPHARMA BIOTECH BERHAD

EX-date15 Oct 2019
Entitlement date16 Oct 2019
Entitlement time 
Entitlement subjectInterim Dividend (with Dividend Re-Investment Plan)
Entitlement descriptionInterim dividend of RM0.01 per ordinary share
Period of interest payment  to  
Financial Year End31 Dec 2019
Share transfer book & register of members will be  to   closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone noTRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHD
Unit 32-01, Level 32, Tower A,
Vertical Business Suite, Avenue 3, Bangsar South,
No. 8, Jalan Kerinchi
59200 Kuala Lumpur

Tel No: (603) 2783 9299
Fax No: (603) 2783 9222
Payment date14 Nov 2019
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers16 Oct 2019
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit 
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable) 
Entitlement indicatorCurrency
CurrencyMalaysian Ringgit (MYR)
Entitlement in Currency0.01
Par Value (if applicable)Malaysian Ringgit (MYR) 0.000

Remarks :
The Board of Directors of Duopharma Biotech Berhad ("Duopharma Biotech" or the "Company") ("Board") has declared a single-tier interim dividend of RM0.01 per ordinary share in Duopharma Biotech ("Duopharma Biotech Shares") in respect of the financial year ending 31 December 2019. The Board has also determined the dividend reinvestment plan ("DRP") would apply to the interim dividend.

Following the above, on behalf of the Board, Mercury Securities Sdn Bhd had on 2 October 2019 announced that the issue price of the new Duopharma Biotech Shares to be issued pursuant to the DRP has been fixed at RM1.25 per Duopharma Biotech Share.

This announcement is dated 2 October 2019.